Search for: "Novartis International AG" Results 41 - 60 of 120
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2010, 6:55 am by Ashby Jones
In the latest example, Bayer AG failed this week to persuade the Delhi High Court to direct India’s chief drug regulator to not give marketing approval to a competitor’s copy of its cancer medicine Nexavar. [read post]
15 Aug 2008, 12:52 pm
The Editorial Board of SCRIPTed - A Journal of Law, Technology & Society is pleased to present its 18th issue, which addresses issues ranging from challenges in medical research governance in Korea, to pharmaceutical litigation (an assessment of the Novartis case in India), to data-protection of administrative records, to privacy in the age of sophisticated location-based technologies, to governance of the mobile communication sector in Korea and US, to a follow-up on our… [read post]
3 May 2015, 10:33 pm
.* No toleration for Novartis - rivastigmine patch patent declared invalidDarren writes up Mr Justice Arnold’s fresh decision in Novartis v Focus, Actavis, Teva [2015] EWHC 1068 (Pat).No cats are skinned, but publisher is "Berned" for Chesterton infringementValentina reports on a Spanish Supreme Court’s decision in a very peculiar Spanish copyright case, where the principle of non-discrimination is addressed and a copyright term of protection is held… [read post]
9 Dec 2014, 3:50 am
He cited the VODKAT and Rihanna cases [Katposts here and here] which appear to suggest that case law has not actually moved very far from its original position.Next to speak was Myrtha Hurtado Rivas (Novartis AG), who gave a strategic overview of the trade mark v unfair competition position from the standpoint of a business that had to make decisions as to how -- and where -- to enforce its rights and protect its interests in the Europe of today -- and beyond. [read post]
13 Aug 2020, 12:38 pm by luiza
  On June 25, 2020, the SEC announced settlement with drug company Novartis AG and its subsidiary Alcon Pte Ltd related to payments made by third parties in Asia and Europe to get doctors (including at state-owned hospitals) to prescribe Novartis drugs. [read post]
24 Aug 2020, 12:00 am by Annsley Merelle Ward
Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
17 Jan 2008, 10:00 pm
: (IP Dragon),China acts to boost patents on publicly funded research: (Intellectual Property Watch),Fighting local protectionism: (China Hearsay),Proposed changes to trade mark law: (International Law Office)DenmarkParallel import not in violation of trade mark rights: (International Law Office),World first record label using creative commons license is Danish: (Innovationpartners)EuropeCroatia and Norway ratify European Patent … [read post]
21 Jul 2013, 5:38 pm by Submitted Posting
Lipimile, Director & Chief Executive Officer, COMESA Competition Commission • Ali Haddou Ruiz, Executive Secretary, The Federal Competition Commission, Mexico • Michele Piergiovanni, Case Manager, European Commission Merger Control Unit, European Commission • Carel Maske, Senior Attorney, Antitrust, Microsoft EMEA • Martin Commons, Senior Competition/Antitrust Counsel, BHP Billiton • Joerg Haering, Division General Counsel Legal & Compliance, Siemens • Susan… [read post]
14 Jul 2010, 6:47 pm by Kelly
Abbott Laboratories Ltd v Medinol Ltd (PatLit) US: Analysis shows patent use codes have doubled since August 2003 (FDA Law Blog) US: House slips pay-for-delay provision into Appropriations Bill (Patent Docs) US: Novartis challenges USPTO’s interim procedure for requesting PTA recalculations (Patent Docs) US: Seven actions related to Enzo’s patents for detecting DNA stayed pending Supreme Court review (Patent Docs) US: Review and correction of the patent term adjustment… [read post]
6 Jul 2010, 9:59 pm
Click here for further details.The decision of the Court of Appeal for England and Wales in Actavis UK Limited v Novartis AG -- which has the distinction of being the most-commented-upon ruling ever to have been posted on this weblog -- was bound to be the subject of an appeal. [read post]
23 Nov 2007, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalReputation and privacy in the online social media world: (IPWar's), McAfee typosquatting study results and implications: (IPWar's),Larry Lessig's comments on how creativity is being strangled by the law: (BLOG@IP::JUR)Two interesting papers on Creative Commons: (CreativeCommons)Friction and 'Warfighting': (IP Think Tank),More on the controversy at WIPO over Kamil Idris'… [read post]
19 Oct 2007, 11:06 am
Martin Kuster, MD MOH, Novartis International AG, Switzerland, presented "Nanoparticles in drug delivery: potential avenues and issues. [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
23 Feb 2015, 2:55 am
.* The Richemont ruling and beyond: dealing with counterfeit websites and the intermediaries that host themKatfriend Tim Behean provides another insightful analysis of Cartier International AG and Others v British Sky Broadcasting Ltd and Others [2014] EWHC 3354 (Ch) [following Eleonora's Katpost here], explaining what Arnold J's decision has achieved, how they go about dealing with blocking injunctions in the United States -- and where we might go… [read post]
27 Nov 2006, 2:20 pm
AstraZeneca PLC and Novartis AG this year each committed to spending $100 million on research and development in China. [read post]
1 Feb 2021, 11:27 am by Anastasiia Kyrylenko
Singh considers two cases, Bayer v Natco and Novartis AG v Union of India, to see how compulsory licensing of pharmaceuticals and evergreening of patents are dealt with by the Indian judiciary.Part VII “Lores of IP during wartime”Arpan Banerjee and Dana Beldiman, in Chapter 14, “International Trade Mark Enforcement Under the Versailles Treaty: A Case Study of Sanatogen”, discuss how the Bombay High Court applied IP-related provisions of the… [read post]
9 Feb 2015, 1:15 am
 * International Intellectual Property: a Handbook of Contemporary ResearchJeremy announces the publication of The Research Handbook on International Intellectual Property, an Edward Elgar Publishing volume which is edited by Daniel J. [read post]
2 Mar 2015, 2:43 pm
It is all about patent law and how subject matter ‘relates’ to other subject matter, he explains. ***** PREVIOUSLY, ON NEVER TOO LATE Never too late 34 [week ending Sunday 22 February] – Bill Gates goes to China | Ms Swift's issue with trade marks | TMs and jurisdiction for on-line infringement cases | UK's Chartered Institute of Patent Attorneys and the EPO | Divani & Divani | UK first in global IP enforcement | SUEPO v EPO | Enterprise v Europcar[2015] EWHC 300 |… [read post]
24 Mar 2019, 3:26 pm
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
9 Feb 2013, 4:04 pm by Larry Catá Backer
  The extent to which the United States participates in the construction of these autonomous international systems may suggest the direction in which government policy may be moving away from the traditional consensus of corporate responsibility to something perhaps entirely new. [read post]